Literature DB >> 8882604

Potentiation by 2,2'-pyridylisatogen tosylate of ATP-responses at a recombinant P2Y1 purinoceptor.

B F King1, C Dacquet, A U Ziganshin, D F Weetman, G Burnstock, P M Vanhoutte, M Spedding.   

Abstract

1. 2,2'-Pyridylisatogen tosylate (PIT) has been reported to be an irreversible antagonist of responses to adenosine 5'-triphosphate (ATP) at metabotropic purinoceptors (of the P2Y family) in some smooth muscles. When a recombinant P2Y1 purinoceptor (derived from chick brain) is expressed in Xenopus oocytes, ATP and 2-methylthioATP (2-MeSATP) evoke calcium-activated chloride currents (ICl,Ca) in a concentration-dependent manner. The effects of PIT on these agonist responses were examined at this cloned P2Y purinoceptor. 2. PIT (0.1-100 microM) failed to stimulate P2Y1 purinoceptors directly but, over a narrow concentration range (0.1-3 microM), caused a time-dependent potentiation (2-5 fold) of responses to ATP. The potentiation of ATP-responses by PIT was not caused by inhibition of oocyte ecto-ATPase. At high concentrations (3-100 microM), PIT irreversibly inhibited responses to ATP with a IC50 value of 13 +/- 9 microM (pKB = 4.88 +/- 0.22; n = 3). PIT failed to potentiate inward currents evoked by 2-MeSATP and only inhibited the responses to this agonist in an irreversible manner. 3. Known P2 purinoceptor antagonists were tested for their ability to potentiate ATP-responses at the chick P2Y1 purinoceptor. Suramin (IC50 = 230 +/- 80 nM; n = 5) and Reactive blue-2 (IC50 = 580 +/- 130 nM; n = 6) reversibly inhibited but did not potentiate ATP-responses. Coomassie brilliant blue-G (0.1-3 microM) potentiated ATP-responses in three experiments, while higher concentrations (3-100 microM) irreversibly inhibited ATP-responses. The results indicated that potentiation and receptor antagonism were dissociable and not a feature common to all known P2 purinoceptor antagonists. 4. In radioligand binding assays, PIT showed a low affinity (pKi < 5) for a range of membrane receptors, including: alpha 1, alpha 2-adrenoceptors, 5-HT1A, 5-HT1B, 5-HT2, 5-HT3, D1, D2, muscarinic, central benzodiazepine, H1, mu-opioid, dihydropyridine and batrachotoxin receptors. PIT showed some affinity (pKi = 5.3) for an adenosine (A1) receptor. 5. In guinea-pig isolated taenia caeci, PIT (12.5-50 microM) irreversibly antagonized relaxations to ATP (3-1000 microM); PIT also directly relaxed the smooth muscle and histamine was used to restore tone. Relaxations to nicotine (10-100 microM), evoked by stimulating intrinsic NANC nerves of taenia caeci preparations in the presence of hyoscine (0.3 microM) and guanethidine (17 microM), were not affected by PIT (50 microM, for 25-60 min). 6. These experiments indicate that PIT causes an irreversible antagonism of ATP receptors but, for recombinant chick P2Y1 purinoceptors, this effect is preceded by potentiation of ATP agonism. The initial potentiation by PIT (and by Coomassie brilliant blue-G) of ATP-responses raises the possibility of designing a new class of modulatory drugs to enhance purinergic transmission at metabotropic purinoceptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8882604      PMCID: PMC1909786          DOI: 10.1111/j.1476-5381.1996.tb16704.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  Characterisation of a recombinant P2Y purinoceptor.

Authors:  J Simon; T E Webb; B F King; G Burnstock; E A Barnard
Journal:  Eur J Pharmacol       Date:  1995-11-30       Impact factor: 4.432

2.  Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol.

Authors:  D Hoyer; G Engel; H O Kalkman
Journal:  Eur J Pharmacol       Date:  1985-11-26       Impact factor: 4.432

3.  Identification of separate receptors for adenosine and adenosine 5'-triphosphate in causing relaxations of the isolated taenia of the guinea-pig caecum.

Authors:  M Spedding; D F Weetman
Journal:  Br J Pharmacol       Date:  1976-06       Impact factor: 8.739

4.  Antagonism of the effects of purinergic nerve stimulation and exogenously applied ATP on the guinea-pig taenia coli by 2-substituted imidazolines and related compounds.

Authors:  D Satchell; G Burnstock; P Dann
Journal:  Eur J Pharmacol       Date:  1973-09       Impact factor: 4.432

5.  The effects of 2-2'-pyridylisatogen tosylate on the electrical activity of smooth muscle of the isolated taenia caeci of the guinea-pig [proceedings].

Authors:  R C Small; M Spedding
Journal:  Br J Pharmacol       Date:  1978-06       Impact factor: 8.739

6.  Coomassie Brilliant Blue G is a more potent antagonist of P2 purinergic responses than Reactive Blue 2 (Cibacron Blue 3GA) in rat parotid acinar cells.

Authors:  S P Soltoff; M K McMillian; B R Talamo
Journal:  Biochem Biophys Res Commun       Date:  1989-12-29       Impact factor: 3.575

7.  Possible involvement of prostaglandins in the action of ATP on guinea-pig uterus.

Authors:  H Moritoki; M Takei; T Kasai; Y Matsumura; Y Ishida
Journal:  J Pharmacol Exp Ther       Date:  1979-10       Impact factor: 4.030

8.  Dual regulation of pancreatic vascular tone by P2X and P2Y purinoceptor subtypes.

Authors:  D Hillaire-Buys; J Chapal; P Petit; M M Loubatières-Mariani
Journal:  Eur J Pharmacol       Date:  1991-07-09       Impact factor: 4.432

9.  Evidence against purinergic inhibitory nerves in the vagal pathway to the opossum lower esophageal sphincter.

Authors:  S Rattan; R K Goyal
Journal:  Gastroenterology       Date:  1980-05       Impact factor: 22.682

10.  Cloning and functional expression of a brain G-protein-coupled ATP receptor.

Authors:  T E Webb; J Simon; B J Krishek; A N Bateson; T G Smart; B F King; G Burnstock; E A Barnard
Journal:  FEBS Lett       Date:  1993-06-14       Impact factor: 4.124

View more
  6 in total

1.  Resolution and concordance in dissecting the compound inhibitory junction potential.

Authors:  Brian F King
Journal:  J Physiol       Date:  2012-04-15       Impact factor: 5.182

Review 2.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

3.  Novel consequences of voltage-dependence to G-protein-coupled P2Y1 receptors.

Authors:  I S Gurung; J Martinez-Pinna; M P Mahaut-Smith
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

Review 4.  Molecular recognition at adenine nucleotide (P2) receptors in platelets.

Authors:  Kenneth A Jacobson; Liaman Mamedova; Bhalchandra V Joshi; Pedro Besada; Stefano Costanzi
Journal:  Semin Thromb Hemost       Date:  2005-04       Impact factor: 4.180

5.  2,2'-Pyridylisatogen tosylate antagonizes P2Y1 receptor signaling without affecting nucleotide binding.

Authors:  Zhan-Guo Gao; Liaman Mamedova; Susanna Tchilibon; Ariel S Gross; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2004-07-15       Impact factor: 5.858

6.  Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373.

Authors:  L Stokes; L-H Jiang; L Alcaraz; J Bent; K Bowers; M Fagura; M Furber; M Mortimore; M Lawson; J Theaker; C Laurent; M Braddock; A Surprenant
Journal:  Br J Pharmacol       Date:  2006-10-09       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.